| European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997–2009) N Adriaenssens, S Coenen, A Versporten, A Muller, G Minalu, C Faes, ... Journal of antimicrobial chemotherapy 66 (suppl_6), vi47-vi56, 2011 | 544 | 2011 |
| Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis S Kodali, VH Thourani, J White, SC Malaisrie, S Lim, KL Greason, ... European heart journal 37 (28), 2252-2262, 2016 | 392 | 2016 |
| Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries N Hens, GM Ayele, N Goeyvaerts, M Aerts, J Mossong, JW Edmunds, ... BMC infectious diseases 9, 1-12, 2009 | 272 | 2009 |
| Impact of preoperative chronic kidney disease in 2,531 high-risk and inoperable patients undergoing transcatheter aortic valve replacement in the PARTNER trial VH Thourani, J Forcillo, N Beohar, D Doshi, R Parvataneni, GM Ayele, ... The Annals of thoracic surgery 102 (4), 1172-1180, 2016 | 91 | 2016 |
| European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997–2009) A Versporten, S Coenen, N Adriaenssens, A Muller, G Minalu, C Faes, ... Journal of antimicrobial chemotherapy 66 (suppl_6), vi13-vi23, 2011 | 89 | 2011 |
| European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997–2009) A Versporten, S Coenen, N Adriaenssens, A Muller, G Minalu, C Faes, ... Journal of Antimicrobial Chemotherapy 66 (suppl_6), vi25-vi35, 2011 | 89 | 2011 |
| European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997–2009) Journal of Antimicrobial Chemotherapy 66 (suppl_6), vi37-vi45, 2011 | 74 | 2011 |
| European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997–2009) Journal of antimicrobial chemotherapy 66 (suppl_6), vi57-vi70, 2011 | 62 | 2011 |
| Blood pressure and arterial load after transcatheter aortic valve replacement for aortic stenosis BR Lindman, CM Otto, PS Douglas, RT Hahn, S Elmariah, NJ Weissman, ... Circulation: Cardiovascular Imaging 10 (7), e006308, 2017 | 57 | 2017 |
| Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement BR Lindman, A Zajarias, HS Maniar, DC Miller, RM Suri, SV Arnold, ... Heart 101 (20), 1656-1664, 2015 | 48 | 2015 |
| Clinical and functional outcomes associated with myocardial injury after transfemoral and transapical transcatheter aortic valve replacement: a subanalysis from the PARTNER … JM Paradis, HS Maniar, JM Lasala, S Kodali, M Williams, BR Lindman, ... Cardiovascular Interventions 8 (11), 1468-1479, 2015 | 44 | 2015 |
| Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: randomized, placebo-controlled trial in healthy adults PJ Goadsby, SJ Tepper, PB Watkins, G Ayele, R Miceli, M Butler, L Severt, ... Cephalalgia 39 (14), 1753-1761, 2019 | 41 | 2019 |
| Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis G Minalu, M Aerts, S Coenen, A Versporten, A Muller, N Adriaenssens, ... Journal of antimicrobial chemotherapy 66 (suppl_6), vi79-vi87, 2011 | 34 | 2011 |
| Dedicated bifurcation stent for the treatment of bifurcation lesions involving large side branches: outcomes from the Tryton confirmatory study P Généreux, I Kumsars, JE Schneider, M Lesiak, B Redfors, K Cornelis, ... JACC: Cardiovascular Interventions 9 (13), 1338-1346, 2016 | 27 | 2016 |
| Pooled individual patient data from five countries were used to derive a clinical prediction rule for coronary artery disease in primary care M Aerts, G Minalu, S Bösner, F Buntinx, B Burnand, J Haasenritter, ... Journal of clinical epidemiology 81, 120-128, 2017 | 25 | 2017 |
| Which intraprocedural thrombotic events impact clinical outcomes after percutaneous coronary intervention in acute coronary syndromes? A pooled analysis of the HORIZONS-AMI and … JD Wessler, P Généreux, R Mehran, GM Ayele, SJ Brener, M McEntegart, ... Cardiovascular Interventions 9 (4), 331-337, 2016 | 24 | 2016 |
| Outcomes of a dedicated stent in coronary bifurcations with large side branches: a subanalysis of the randomized TRYTON bifurcation study P Généreux, A Kini, M Lesiak, I Kumsars, G Fontos, T Slagboom, I Ungi, ... Catheterization and Cardiovascular Interventions 87 (7), 1231-1241, 2016 | 21 | 2016 |
| Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change J Mebis, H Jansens, G Minalu, G Molenberghs, WA Schroyens, ... Infection and drug resistance, 53-61, 2010 | 21 | 2010 |
| Quantifying ischemic risk after percutaneous coronary intervention attributable to high platelet reactivity on clopidogrel (from the assessment of dual antiplatelet therapy … B Redfors, O Ben-Yehuda, SH Lin, A Furer, AJ Kirtane, B Witzenbichler, ... The American Journal of Cardiology 120 (6), 917-923, 2017 | 20 | 2017 |
| Coronary heart disease in primary care: accuracy of medical history and physical findings in patients with chest pain–a study protocol for a systematic review with individual … J Haasenritter, M Aerts, S Bösner, F Buntinx, B Burnand, L Herzig, ... BMC family practice 13, 1-10, 2012 | 18 | 2012 |
Niel HensProfessor of BiostatisticsVerified email at uhasselt.be
